Literature DB >> 2605874

Central nervous system involvement in haematological malignancies.

T Sheehan1, R J Cuthbert, A C Parker.   

Abstract

We have reviewed our experience of central nervous system (CNS) involvement in 540 patients with lymphoma or acute leukaemia treated at the Royal Infirmary of Edinburgh between 1979 and 1987. CNS invasion is a significant problem in acute lymphoblastic leukaemia but may well respond to treatment, while in acute non-lymphoblastic leukaemia this complication occurs too infrequently to justify routine CNS prophylaxis. CNS involvement in Hodgkin's disease or non-Hodgkin's lymphoma (NHL) of low-grade malignancy was uncommon, exclusively of the extradural variety, and did not appear to alter the ultimate prognosis. Diffuse leptomeningeal involvement occurred with significant frequency in more aggressive NHL, often while the disease was in systemic remission or during remission induction. The prognosis for leptomeningeal disease or intracranial mass lesions was extremely poor and some form of CNS prophylaxis may be justified in aggressive NHL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605874     DOI: 10.1111/j.1365-2257.1989.tb00231.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  6 in total

Review 1.  Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.

Authors:  C Megan Ogilvie; Sarah Payne; Jane Evanson; T Andrew Lister; Ashley B Grossman
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Lymphomatous meningitis in AIDS-related systemic non-Hodgkin's lymphoma: a report of eight cases.

Authors:  R H Enting; R A Esselink; P Portegies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 3.  Pituitary lymphoma: a case report and literature review.

Authors:  R A Mathiasen; R Jarrahy; S T Cha; K Kovacs; V S Herman; E Ginsberg; H K Shahinian
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

4.  CNS Hodgkin lymphoma.

Authors:  Elizabeth R Gerstner; Lauren E Abrey; David Schiff; Andrés J M Ferreri; Andrew Lister; Silvia Montoto; Richard Tsang; Eckhard Thiel; Francesc Graus; Dirk Behringer; Gerald Illerhaus; Susan Weaver; Patrick Wen; Alfredo Voloschin; Nancy Lee Harris; Tracy T Batchelor
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

Review 5.  Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment: case report and review of the literature.

Authors:  Christoph Henkenberens; Anke Franzke; Peter Raab; Ilske Oschlies; Wolfram Klapper; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2014-05-14       Impact factor: 3.621

6.  Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.

Authors:  Janet L Franklin; Jonathan Finlay
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.